Author

W. Maury

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 5

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:host-pathogen & immune response· 5 Approach:experimental assay· 4 Organism:human· 3 Organism:mouse· 2 Assay:metagenomics· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

D. Bohan· 2 shared H. Haim· 2 shared K. J. Rogers· 2 shared K. Rogers· 2 shared N. Ruggio· 2 shared A. E. Merrill· 1 shared A. R. Rojas Chavez· 1 shared B. Brunton· 1 shared

Activity by Year

2018-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 19 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

D. Bohan

Mutual co-authors in cluster

Author profile →

5 papers

Recent·Most cited

Epitranscriptomic N6-methyladenosine profile of SARS-CoV-2-infected human lung epithelial cells

S. Phillips, S. Khadka, D. Bohan, C. E. Espada, W. Maury, L. Wu

This study examines how m6A modification of host cell RNAs changes during SARS-CoV-2 infection in human lung epithelial cells and identifies associated biological pathways and regulators.

bioRxiv · Aug 1, 2022Microbiology

Limited variation between SARS-CoV-2-infected individuals in domain specificity and relative potency of the antibody response against the spike glycoprotein

H. A. Van Ert, D. W. Bohan, K. J. Rogers, M. Fili, A. R. Rojas Chavez, E. Qing, C. Han, S. M. Dempewolf, G. Hu, N. Schwery, K. M. Sevcik, N. Ruggio, D. Boyt, M. Pentella, T. Gallagher, , H. Haim

The paper analyzes antibody responses in SARS-CoV-2-infected individuals, finding limited variation in domain specificity and relative neutralization potency across subjects.

bioRxiv · Aug 4, 2021Microbiology

Phosphatidylserine Receptors Enhance SARS-CoV-2 Infection: AXL as a Therapeutic Target for COVID-19

D. Bohan, H. Van Ert, N. Ruggio, K. J. Rogers, M. Baddredine, J. A. A. Briseno, R. A. Rojas Chavez, B. Gao, T. Stokowy, E. Christakou, D. Micklem, G. Gausdal, H. Haim, J. Minna, J. B. Lorens, W. Maury

This study identifies PS receptors, including AXL, as facilitators of SARS-CoV-2 infection by enhancing virus entry into human lung cells, suggesting AXL as a therapeutic target for COVID-19.

bioRxiv · Jun 15, 2021Microbiology

TF protein of Sindbis virus antagonizes host type I interferon responses in a palmitoylation-dependent manner

K. Rogers, S. Jones-Burrage, W. Maury, S. Mukhopadhyay

This study shows that Sindbis virus TF protein antagonizes host type I interferon responses, with palmitoylation being essential for this function.

bioRxiv · Dec 13, 2019Microbiology

TIM-1 SERVES AS A NONREDUNDANT RECEPTOR FOR EBOLA VIRUS, ENHANCING VIREMIA AND PATHOGENESIS

B. Brunton, K. Rogers, E. K. Phillips, R. B. Brouillette, R. Bouls, N. S. Butler, W. Maury

This study shows TIM-1 enhances Ebola virus pathogenesis by increasing virus load and mortality in mice, suggesting TIM-1 as a nonredundant receptor for EBOV.

bioRxiv · Nov 8, 2018Microbiology